Effect of astragaloside IV on intestinal barrier dysfunction in septic mice

李曼,谢淑华,杨涛,王蕾,崔艳苓,褚童,耿立成
DOI: https://doi.org/10.3760/cma.j.cn131073.20200316.01223
2020-01-01
Abstract:Objective:To evaluate the effect of astragaloside IV (AS-IV) on intestinal barrier dysfunction in septic mice.Method:One hundred and twenty clean-grade healthy male C57BL/6J mice, aged 6-8 weeks, weighing 20-25 g, were divided into 4 groups ( n=30 each) using a random number table method: sham operation group (group SH), sham operation plus AS-IV group (group SH+ A), sepsis group (group S), and sepsis plus AS-IV group (group S+ A). The model of sepsis was established by cecal ligation and puncture (CLP) in anesthetized mice.AS-IV 3 mg/kg was injected via the tail vein at 1 h after CLP in group SH+ A and group S+ A.The equal volume of dimethyl sulfoxide was injected instead in group SH and group S. The survival rate of mice in each group was recorded at 7 days after operation.Blood samples were collected from the cardiac apex at 24 h after CLP operation to measure concentrations of interleukin-1beta (IL-1β) and IL-18 in serum by enzyme-linked immunosorbent assay.Mice were then sacrificed, and intestinal tissues were removed to determine contents of IL-1β and IL-18 (by enzyme-linked immunosorbent assay), transepithelial electrical resistance (TER) (by Ussing chamber system), expression of NOD-like receptor family pyrin domain containing 3 (NLRP3) and caspase-1 protein and mRNA (by Western blot or real-time polymerase chain reaction) and to examine the pathological changes (using HE staining). Intestinal damage was assessed and scored according to Chiu. Results:Compared with group SH, the 7-day survival rate and TER were significantly decreased, the concentrations of IL-1β and IL-18 in serum, Chiu′s score, contents of IL-1β and IL-18 were increased, and the expression of NLRP3 and caspase-1 protein and mRNA was up-regulated in group S and group S+ A ( P<0.05). Compared with group S, the 7-day survival rate and TER were significantly increased, the concentrations of IL-1β and IL-18 in serum, Chiu′s score, contents of IL-1β and IL-18 were decreased, and the expression of NLRP3 and caspase-1 protein and mRNA was down-regulated in group S+ A ( P<0.05). There was no significant difference in the above indicators between group SH+ A and group SH ( P>0.05). Conclusion:AS-IV can improve sepsis-induced intestinal barrier dysfunction in mice, and the mechanism may be related to inhibiting the activation of NLRP3/caspase-1 signaling pathway and thus reducing inflammatory responses.
What problem does this paper attempt to address?